Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma

PURPOSE: Sorafenib is an effective systemic agent for advanced hepatocellular carcinoma. To increase its efficacy, we evaluated the feasibility and benefit of sorafenib combined with radiotherapy. MATERIALS AND METHODS: From July 2007 to July 2011, 31 patients were treated with a daily dose of 800 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Jihye, Seong, Jinsil, Lee, Ik Jae, Kim, Jun Won, Han, Kwang-Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743177/
https://www.ncbi.nlm.nih.gov/pubmed/23918567
http://dx.doi.org/10.3349/ymj.2013.54.5.1178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743177/
https://www.ncbi.nlm.nih.gov/pubmed/23918567
http://dx.doi.org/10.3349/ymj.2013.54.5.1178

Ejemplares similares